NURS 5434 FAMILY III FINAL
COMPREHENSIVE EXAM SCRIPT VERIFIED
QUESTIONS ANSWERS ACCURATE
SOLUTIONS PACK
●● **USPSTF Grade B**
Answer: Recommended preventive service with high certainty of
moderate net benefit or moderate certainty of moderate-to-substantial
net benefit.
●● **USPSTF Grade C**
Answer: Preventive service offered selectively based on individual risk,
preferences, and shared decision-making because net benefit is small.
●● **USPSTF Grade D**
Answer: Preventive service that should be discouraged because harms
outweigh benefits or there is no net benefit.
●● **USPSTF Grade I**
Answer: Preventive service with insufficient evidence to recommend for
or against routine use.
●● **Colorectal Cancer Screening**
,Answer: Routine screening begins at age 45. Ages 45-49 are Grade B
and ages 50-75 are Grade A. Common options include annual FIT or
colonoscopy every 10 years.
●● **Breast Cancer Screening**
Answer: Biennial mammography for women ages 40-74.
●● **Cervical Cancer Screening Age 21-29**
Answer: Pap cytology alone every 3 years.
●● **Cervical Cancer Screening Age 30-65**
Answer: Pap every 3 years, or primary hrHPV testing every 5 years, or
cotesting every 5 years.
●● **When to Stop Cervical Cancer Screening**
Answer: After age 65 if there has been adequate prior normal screening
and the patient is not otherwise high risk.
●● **Prostate-Specific Antigen Screening Age 55-69**
Answer: Shared decision-making recommendation rather than routine
universal screening.
●● **Prostate-Specific Antigen Screening Age 70 and Older**
,Answer: Grade D recommendation; do not routinely screen.
●● **Lung Cancer Screening**
Answer: Annual low-dose CT for adults ages 50-80 with a 20 pack-year
smoking history who currently smoke or quit within the last 15 years.
●● **HIV Screening**
Answer: One-time screening for adolescents and adults ages 15-65, with
additional screening for high-risk patients.
●● **Hepatitis C Screening**
Answer: One-time screening for adults ages 18-79.
●● **Ovarian Cancer Screening**
Answer: Do not screen asymptomatic average-risk women; this is a
Grade D recommendation.
●● **Tdap Vaccine**
Answer: One-time adult Tdap if never received, then Td or Tdap booster
every 10 years.
●● **Tdap in Pregnancy**
, Answer: Administer during every pregnancy, ideally between 27 and 36
weeks.
●● **Influenza Vaccine**
Answer: Annual vaccination for adults.
●● **Shingrix Vaccine**
Answer: Recombinant zoster vaccine recommended for adults age 50
and older as a 2-dose series separated by 2-6 months.
●● **HPV Vaccine Catch-Up**
Answer: Routinely recommended through age 26 if not previously
completed.
●● **HPV Vaccine Ages 27-45**
Answer: Shared decision-making recommendation.
●● **PCV20**
Answer: Pneumococcal conjugate vaccine option that is complete by
itself with no PPSV23 needed afterward.
●● **PCV15**
COMPREHENSIVE EXAM SCRIPT VERIFIED
QUESTIONS ANSWERS ACCURATE
SOLUTIONS PACK
●● **USPSTF Grade B**
Answer: Recommended preventive service with high certainty of
moderate net benefit or moderate certainty of moderate-to-substantial
net benefit.
●● **USPSTF Grade C**
Answer: Preventive service offered selectively based on individual risk,
preferences, and shared decision-making because net benefit is small.
●● **USPSTF Grade D**
Answer: Preventive service that should be discouraged because harms
outweigh benefits or there is no net benefit.
●● **USPSTF Grade I**
Answer: Preventive service with insufficient evidence to recommend for
or against routine use.
●● **Colorectal Cancer Screening**
,Answer: Routine screening begins at age 45. Ages 45-49 are Grade B
and ages 50-75 are Grade A. Common options include annual FIT or
colonoscopy every 10 years.
●● **Breast Cancer Screening**
Answer: Biennial mammography for women ages 40-74.
●● **Cervical Cancer Screening Age 21-29**
Answer: Pap cytology alone every 3 years.
●● **Cervical Cancer Screening Age 30-65**
Answer: Pap every 3 years, or primary hrHPV testing every 5 years, or
cotesting every 5 years.
●● **When to Stop Cervical Cancer Screening**
Answer: After age 65 if there has been adequate prior normal screening
and the patient is not otherwise high risk.
●● **Prostate-Specific Antigen Screening Age 55-69**
Answer: Shared decision-making recommendation rather than routine
universal screening.
●● **Prostate-Specific Antigen Screening Age 70 and Older**
,Answer: Grade D recommendation; do not routinely screen.
●● **Lung Cancer Screening**
Answer: Annual low-dose CT for adults ages 50-80 with a 20 pack-year
smoking history who currently smoke or quit within the last 15 years.
●● **HIV Screening**
Answer: One-time screening for adolescents and adults ages 15-65, with
additional screening for high-risk patients.
●● **Hepatitis C Screening**
Answer: One-time screening for adults ages 18-79.
●● **Ovarian Cancer Screening**
Answer: Do not screen asymptomatic average-risk women; this is a
Grade D recommendation.
●● **Tdap Vaccine**
Answer: One-time adult Tdap if never received, then Td or Tdap booster
every 10 years.
●● **Tdap in Pregnancy**
, Answer: Administer during every pregnancy, ideally between 27 and 36
weeks.
●● **Influenza Vaccine**
Answer: Annual vaccination for adults.
●● **Shingrix Vaccine**
Answer: Recombinant zoster vaccine recommended for adults age 50
and older as a 2-dose series separated by 2-6 months.
●● **HPV Vaccine Catch-Up**
Answer: Routinely recommended through age 26 if not previously
completed.
●● **HPV Vaccine Ages 27-45**
Answer: Shared decision-making recommendation.
●● **PCV20**
Answer: Pneumococcal conjugate vaccine option that is complete by
itself with no PPSV23 needed afterward.
●● **PCV15**
